Duloxetine loaded-microemulsion system to improve behavioral activities by upregulating serotonin and norepinephrine in brain for the treatment of depression
Authors:
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 99, 83-95
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Brain delivery of intranasal in situ gel of nanoparticulated polymeric carriers containing antidepressant drug: behavioral and biochemical assessmentJournal of Drug Targeting, 2014
- Formulation consideration and characterization of microemulsion drug delivery system for transnasal administration of carbamazepineBulletin of Faculty of Pharmacy, Cairo University, 2013
- Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglyceridesColloids and Surfaces B: Biointerfaces, 2012
- Duloxetine HCl Lipid Nanoparticles: Preparation, Characterization, and Dosage Form DesignAAPS PharmSciTech, 2011
- Studies on the formation of bifenthrin oil-in-water nano-emulsions prepared with mixed surfactantsColloids and Surfaces A: Physicochemical and Engineering Aspects, 2011
- Synthesis and surface activity properties of alkylphenol polyoxyethylene nonionic trimeric surfactantsApplied Surface Science, 2010
- Surface activity and emulsification properties of hydrophobically modified dextrinsColloids and Surfaces A: Physicochemical and Engineering Aspects, 2010
- Molecular epidemiology of major depressive disorderEnvironmental Health and Preventive Medicine, 2009
- Duloxetine: A Dual Serotonin‐Norepinephrine Reuptake Inhibitor for Treatment of Major Depressive DisorderPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- Behavioral organization is independent of locomotor activity in 129 and C57 mouse strains1Published on the World Wide Web on 16 February 1999.1Brain Research, 1999